Treatment
Spironolactone clinical trials
We’re tracking 26 recruiting studies that include Spironolactone, each written for real people, not researchers, below.
Recruiting studies
- NCT02378805Recruiting
Alport syndrome registry to help delay kidney failure
This is a registry that collects information from people with Alport syndrome to better understand the disease and how to delay kidney failure. It may help researchers learn which factors and treatments are most important over time.
Göttingen, Lower SaxonyAges Any age - NCT07483177RecruitingPhase 1/Phase 2
Heart study for enlarged aorta
This trial tests a treatment to help people with a mildly enlarged ascending aorta. It aims to slow down growth and prevent future heart problems.
Rochester, MinnesotaAges 18 years+
Common questions
- Are there clinical trials studying Spironolactone?
- Yes. Clin2 currently lists 26 recruiting studies that include Spironolactone, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Spironolactone trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Spironolactone an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Spironolactone or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.